Detectability of Plasma-Derived Circulating Tumor DNA Panel in Patients Undergoing Primary Treatment for Uveal Melanoma.

导出 OA

翻译打印收藏纠错

作者： Jasmine H,Francis ^[1] ; Christopher A,Barker ^[2] ; A Rose,Brannon ^[3] ; Julia,Canestraro ^[4] ; Melissa,Robbins ^[1] ; Christina E,Swartzwelder ^[1] ; Sara,Levine ^[5] ; Crystal,Law ^[1] ; Michael F,Berger ^[1] ; Alexander,Shoushtari ^[4] ; David H,Abramson ^[6]

作者单位： Department of Surgery (Ophthalmic Oncology Service), Memorial Sloan Kettering Cancer Center, New York, New York, United States. ^[1] Department of Ophthalmology, Weill Cornell Medical College, New York, New York, United States. ^[2] Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, United States. ^[3] Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, United States. ^[4] Department of Surgery (Head and Neck Service), Memorial Sloan Kettering Cancer Center, New York, New York, United States. ^[5] Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, United States. ^[6] Department of Medicine, Weill Cornell Medical College, New York, New York, United States. ^[7]

主题词人类(Humans);葡萄膜肿瘤(Uveal Neoplasms);黑色素瘤(Melanoma);高通量核苷酸序列分析(High-Throughput Nucleotide Sequencing)

DOI 10.1167/iovs.63.13.17

PMID 36525262

发布时间 2023-02-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交